close
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Harmony Biosciences

Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series
From Harmony Biosciences
Via Business Wire
Tickers HRMY
Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts
From Harmony Biosciences
Via Business Wire
Tickers HRMY
Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates
From Harmony Biosciences
Via GlobeNewswire
Tickers HRMY
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Starting at $3.75/week.

Subscribe Today